Comparative effectiveness and safety of intravenous methylprednisolone and tacrolimus monotherapy in ocular myasthenia gravis with unsatisfactory prednisone responses: a retrospective study
Oral prednisone has been recognized as the first-line therapy for the treatment of ocular myasthenia gravis (OMG). However, its long-term use is complicated by numerous adverse effects and is ineffective for s...
Source: Orphanet Journal of Rare Diseases - Category: Internal Medicine Authors: Kai-Yue Zhang, Wei-Wei Duan, Yue-Bei Luo, Yi Li, Jue Hu and Huan Yang Tags: Research Source Type: research
More News: Internal Medicine | Methylprednisolone | Myasthenia Gravis | Prednisone | Prograf | Rare Diseases | Study | Tacrolimus